jili slot png

jili slot png Rape allegation against Jay-Z won’t impact NFL's relationship with music mogul, Goodell saysOn Monday, faced with the impossibility of passing the social security budget, and despite the many concessions made to the far right, French Prime Minister Michel Barnier decided to use Article 49.3 of the Constitution, which allows the government to force through legislation unless a motion of no confidence is passed. The primary aim was to implement the social security budget. This decision opens up the possibility for members of parliament to table a motion of censure against Barnier’s government. On Monday evening, the left-wing parties (124 MPs) and right-wing parties (Marine Le Pen’s RN and Eric Ciotti’s supporters, 140 MPs) decided to submit a motion of no confidence. These motions of no confidence will be analysed and voted on in the National Assembly no earlier than the evening of Wednesday, 4 December. To bring down the government, a majority of the 577 MPs must support them. To obtain a majority, the left-wing parties must vote with the far-right RN on the same motion of censure. This would lead to the fall of the government. At this stage, this is the most likely scenario, as Le Pen has indicated that her party is prepared to vote in favour of the motion of censure tabled by left-wing MPs. While a last-minute twist is still possible, all indications are that the government will have fallen by the end of the week, less than three months after its appointment. This will usher in a new period of political uncertainty. There will be no dissolution of the National Assembly or early elections before July 2025, as the Constitution provides for a minimum period of one year between elections. Then, based on the forces present, President Emmanuel Macron will have to appoint a new prime minister. Two scenarios are possible: either a new government is appointed in December, or there is no new government until the end of 2024. Given the challenges in appointing Barnier as prime minister, the likelihood of finding a replacement quickly is highly uncertain. With an extremely polarised National Assembly divided into three major camps – left, centre-right and extreme right – who are unable to reach a compromise, the risk of a new vote of no confidence for any new government is very high. In any case, it is almost certain that there will not be a majority to pass a state budget or a social security budget before the end of the year. The last few weeks have shown that MPs and Senators are extremely divided on how to restore public finances and that a consensus is virtually impossible. It seems unlikely that France will have a 2025 budget. However, this doesn’t imply a shutdown where France can’t meet its financial obligations. A provisional budget, likely mirroring the 2024 budget, will probably be implemented. Such a budget will not rectify the trajectory of public spending. The public deficit is expected to exceed 6% of GDP in 2024. The Barnier government had hoped to reduce it to 5% by 2025, but without a budget voted for in 2025, this target will not be met. The provisional budget will be slightly restrictive, as tax scales will not be adjusted for inflation, but will not contain any real savings measures. As a result, it will not be enough to set the trajectory of French public finances in the desired direction and will not respect the commitments made by France to the European authorities. At a time when economic growth in France is slowing markedly, this is bad news. The public deficit will remain high, debt will continue to grow and the next government – whenever that may be – will have an even tougher task to put public finances right. In short, the political situation will delay and likely complicate the recovery of public finances, but it will eventually occur. The only difference is that the starting point will be later. This French political stand-off is just one more negative for the euro. With the eurozone economy facing the threat of tariffs in 2025 and the region lacking any prospect of cohesive fiscal support, the potential fall of the French government merely adds to views that the ECB will have to do the heavy lifting in 2025. Notably, short-dated yield spreads have moved against EUR/USD as this French crisis comes to a head, pushing EUR/USD back below 1.05. Seasonally the dollar is weak in December. Europe will remain a drag on EUR/USD into year-end. With both the French and German governments in limbo, any EUR/USD bounce will have to be driven by softer US data and a dovish 25bp rate cut from the Fed on 18 December. Overall, we have a year-end target for EUR/USD at 1.05, but see the risks skewed towards the 1.02/03 area. Typically, EUR/CHF comes under pressure when European politics hit the headlines. We are a little surprised it is still trading above 0.93 and expect it to press 0.92 should it become clear that the Swiss National Bank cannot cut rates as deeply as the ECB next year. French bond spreads already reflect a lot of pessimism The 10y yield spread of French government bonds over their German peers widened to 88bp on Monday. Further widening looks likely as politics enters a new phase of elevated uncertainty. Looking at relative valuation across the entire eurozone bond spectrum, there are two key takeaways. First, the spillover to other markets has been limited. Italy, for instance, is still at spread levels closer to their tightest since 2021. Second, markets had been wary about the prospects of quickly solving French fiscal problems to begin with, reflecting an expectation of looming rating downgrades. Following the latest widening, French 10y spreads over swaps are more in line with an “A-“ rating rather than its current “AA-“ – three notches lower. In fact, French spreads are already well above Spain’s and now are on a par with those of Greece. Government fragility was always part of the picture, even if not expected to come to a head quite so soon. Though it may take a while, a clearer picture going forward should allow spreads to recover from these stretched levels. However, France won’t be able to avoid a more lasting downgrade in its implied rating by the market, making the spread levels against Bunds seen before June’s elections seem quite distant. Source: ING

Peavy's 24 help Georgetown beat Albany 100-68SAN FRANCISCO (AP) — Google on Wednesday unleashed another wave of artificial intelligence designed to tackle more of the work and thinking done by humans as it tries to stay on the technology's cutting edge while also trying to fend off regulatory threats to its empire. The next generation of Google's AI is being packaged under the Gemini umbrella, which was unveiled a year ago . Google is framing its release of Gemini 2.0 as a springboard for AI agents built to interpret images shown through a smartphone, perform a variety of tedious chores, remember the conversations consumers have with people, help video game players plot strategy and even tackle the task of doing online searches. In a blog post , Google CEO Sundar Pichai predicted the technology contained in Gemini 2.0 will “understand more about the world around you, think multiple steps ahead and take action on your behalf, with your supervision.” It's a similar goal being pursued by hard-charging rivals such as OpenAI, with its chatGPT technology, and industry powerhouse such as Microsoft with a variety of similar tools on its Windows software. A lot of Google's latest AI technology will initially be confined to test groups and subscribers who pay $20 per month for Gemini Advanced, but some features will be made available through its search engine and mobile apps. Google is planning wider releases next year that will include the technology popping up in its smorgasbord of free products, including its Chrome browser, digital maps and YouTube. Besides trying to outshine OpenAI and other ambitious startups, Google is also trying to stay a step ahead of Apple as that trendsetting company begins to blend AI into its latest iPhones and other devices. After releasing a software update enabling the first bundle of the iPhone's “Apple Intelligence” features that spruced up the device's Siri assistant, another batch of the AI technology came out with a free software update that was also released Wednesday. Google is pushing forward with its latest AI advances even as the U.S. Justice Department is trying to break up the Mountain View, California, company to prevent further abusive practices by its dominant search engine, which was declared an illegal monopoly by a federal judge earlier this year as part of a landmark antitrust case. Among other things, Gemini 2.0 is supposed to improve the AI overviews that Google began highlighting in its search results over its traditional listing of the most pertinent links to websites earlier this year in response to AI-powered “answer engines” such as Perplexity. Story continues below video After the AI overviews initially produced some goofy suggestions, including putting glue on pizza , Google refined the technology to minimize such missteps. Now, company executives are promising things are going to get even better with Gemini 2.0, which Pichai said will be able to engage in more human-like reasoning while solving more advanced math problems and even churn out some computer code. The improvements to AI Overviews will initially only appear to a test audience before a wider release next year. The technological upgrade is also supposed to infuse a still-experimental universal AI agent dubbed “Project Astra,” with even more smarts and versatility, enabling people to have more meaningful and helpful conversations with the technology. In a show of confidence, Google said it will expand the number of people testing Project Astra without providing any specifics of the group's size. As part of Gemini 2.0, Google is also going to begin testing an extension to Chrome called “Project Mariner,” which can be turned on to do online searches and sift through the results so people don't won't have to bother. If the U.S. Department of Justice gets its way, Google will be forced to sell or spin off Chrome as part of its punishment for deploying its search engine in ways that stifled competition and potential innovation. Google has ridiculed the Justice Department's proposal as “overly broad” and vowed to resist any attempt to break up the company during federal court hearings scheduled to begin in Washington D.C. next spring. Even if those proceedings culminate in a court order mandating a breakup, Google could still appeal in a process that could take years to resolve while it continues its AI expansion. “I can’t wait to see what this next era brings,” Pichai wrote in his blog post, signaling the company doesn't believe it will be deterred by regulators.Larson Financial Group LLC boosted its stake in shares of Catalyst Pharmaceuticals, Inc. ( NASDAQ:CPRX – Free Report ) by 27,218.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,005 shares of the biopharmaceutical company’s stock after purchasing an additional 2,994 shares during the period. Larson Financial Group LLC’s holdings in Catalyst Pharmaceuticals were worth $60,000 as of its most recent filing with the SEC. A number of other hedge funds have also recently bought and sold shares of CPRX. Susquehanna Fundamental Investments LLC acquired a new stake in shares of Catalyst Pharmaceuticals in the 2nd quarter valued at approximately $258,000. Integral Health Asset Management LLC bought a new stake in Catalyst Pharmaceuticals during the second quarter worth $4,260,000. GSA Capital Partners LLP acquired a new stake in Catalyst Pharmaceuticals in the third quarter valued at $625,000. Vanguard Group Inc. grew its position in shares of Catalyst Pharmaceuticals by 12.1% in the 1st quarter. Vanguard Group Inc. now owns 7,980,661 shares of the biopharmaceutical company’s stock valued at $127,212,000 after acquiring an additional 860,244 shares during the period. Finally, Allspring Global Investments Holdings LLC increased its stake in shares of Catalyst Pharmaceuticals by 146.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 366,444 shares of the biopharmaceutical company’s stock worth $7,285,000 after purchasing an additional 217,956 shares during the last quarter. 79.22% of the stock is currently owned by institutional investors. Catalyst Pharmaceuticals Stock Performance Shares of Catalyst Pharmaceuticals stock opened at $22.07 on Friday. The firm has a 50-day moving average of $21.23 and a 200-day moving average of $18.72. Catalyst Pharmaceuticals, Inc. has a 52-week low of $13.00 and a 52-week high of $24.27. The stock has a market cap of $2.63 billion, a PE ratio of 18.70, a PEG ratio of 3.44 and a beta of 0.75. Insider Buying and Selling at Catalyst Pharmaceuticals Analyst Ratings Changes Several brokerages recently issued reports on CPRX. HC Wainwright reiterated a “buy” rating and issued a $30.00 target price on shares of Catalyst Pharmaceuticals in a research note on Friday, November 8th. Stephens began coverage on Catalyst Pharmaceuticals in a research note on Monday, November 18th. They set an “overweight” rating and a $35.00 target price for the company. Truist Financial increased their price target on Catalyst Pharmaceuticals from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Monday, November 11th. Citigroup lifted their price objective on shares of Catalyst Pharmaceuticals from $27.00 to $31.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Finally, StockNews.com raised shares of Catalyst Pharmaceuticals from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 9th. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $31.14. View Our Latest Stock Report on CPRX About Catalyst Pharmaceuticals ( Free Report ) Catalyst Pharmaceuticals, Inc, a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. See Also Receive News & Ratings for Catalyst Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalyst Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .

Algert Global LLC raised its holdings in John B. Sanfilippo & Son, Inc. ( NASDAQ:JBSS – Free Report ) by 156.2% during the third quarter, HoldingsChannel reports. The firm owned 7,860 shares of the company’s stock after acquiring an additional 4,792 shares during the quarter. Algert Global LLC’s holdings in John B. Sanfilippo & Son were worth $741,000 at the end of the most recent reporting period. Several other hedge funds and other institutional investors also recently modified their holdings of the business. GSA Capital Partners LLP acquired a new stake in John B. Sanfilippo & Son in the third quarter valued at about $2,610,000. Pacer Advisors Inc. lifted its holdings in shares of John B. Sanfilippo & Son by 6.5% in the second quarter. Pacer Advisors Inc. now owns 345,252 shares of the company’s stock worth $33,548,000 after acquiring an additional 21,069 shares during the last quarter. Bank of Montreal Can acquired a new stake in shares of John B. Sanfilippo & Son in the 2nd quarter valued at approximately $1,062,000. American Century Companies Inc. grew its holdings in shares of John B. Sanfilippo & Son by 10.0% during the 2nd quarter. American Century Companies Inc. now owns 115,376 shares of the company’s stock valued at $11,211,000 after purchasing an additional 10,514 shares during the last quarter. Finally, Oliver Luxxe Assets LLC increased its position in John B. Sanfilippo & Son by 82.8% during the 3rd quarter. Oliver Luxxe Assets LLC now owns 17,434 shares of the company’s stock worth $1,644,000 after purchasing an additional 7,895 shares in the last quarter. Institutional investors own 70.64% of the company’s stock. Analysts Set New Price Targets Separately, StockNews.com lowered shares of John B. Sanfilippo & Son from a “buy” rating to a “hold” rating in a research report on Monday, November 4th. John B. Sanfilippo & Son Trading Up 1.9 % Shares of JBSS stock opened at $86.35 on Friday. John B. Sanfilippo & Son, Inc. has a twelve month low of $79.07 and a twelve month high of $108.96. The stock’s fifty day simple moving average is $89.82 and its 200 day simple moving average is $95.07. The company has a quick ratio of 0.66, a current ratio of 2.06 and a debt-to-equity ratio of 0.02. The firm has a market capitalization of $1.00 billion, a P/E ratio of 18.57 and a beta of 0.11. John B. Sanfilippo & Son Profile ( Free Report ) John B. Sanfilippo & Son, Inc, through its subsidiary, JBSS Ventures, LLC, processes and distributes tree nuts and peanuts in the United States. The company offers raw and processed nuts, including almonds, pecans, peanuts, black walnuts, English walnuts, cashews, macadamia nuts, pistachios, pine nuts, Brazil nuts, and filberts in various styles and seasonings. Featured Articles Want to see what other hedge funds are holding JBSS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for John B. Sanfilippo & Son, Inc. ( NASDAQ:JBSS – Free Report ). Receive News & Ratings for John B. Sanfilippo & Son Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John B. Sanfilippo & Son and related companies with MarketBeat.com's FREE daily email newsletter .

Angel Oak Financial Strategies Income Term Trust Declares December 2024 DistributionSÃO PAULO , Dec. 3, 2024 /PRNewswire/ -- Sigma Lithium Corporation (TSXV/NASDAQ: SGML, BVMF: S2GM34) (" Sigma Lithium " or the " Company "), a leading global lithium producer dedicated to powering the next generation of electric vehicles with carbon-neutral, socially and environmentally sustainable lithium concentrate, announces that it is in the process of loading 27,500 tonnes of its already produced Quintuple Zero Green Lithium for shipment from the Port of Vitoria to IRH Global Trading LTD in Abu Dhabi , demonstrating its increased operational excellence and its ability to meet both operational and sales targets. The provisional price (6% Li 2 O, CIF China) for this shipment is set at 8.25% of the battery-grade lithium carbonate price quoted on the Guangzhou Futures Exchange (GFEX) as of the shipment date. Sigma Lithium's operational and shipping consistency highlights the Company's robust production capabilities following the successful implementation of several efficiency initiatives at the Greentech Industrial Plant during the four-day annual maintenance shutdown in November. During this month we achieved continuous production of over 850 tonnes per day of lithium oxide for several consecutive days, reaching peak days of 900 tonnes per day, demonstrating the enhanced production capabilities of the Greentech Industrial Plant. As a result, the annualized production run rate reached full capacity of 270,000 tonnes and the Company expects to maintain this annualized production level going forward. " Our ability to maintain a consistent monthly shipment cadence is a clear reflection of our operational excellence, and reliability as a mature producer. It also highlights the stability we have achieved in the use of our proprietary dense media separation technology to produce lithium oxide at our Greentech Industrial Plant, " said Ana Cabral , CEO of Sigma Lithium. "We are delighted with ongoing partnership with IRH in Abu Dhabi which enhances our commercial flexibility to effectively navigate lithium demand seasonality. This collaboration enables us to capitalize on every opportunity to maximize business performance and secure better lithium pricing, even in the current market environment. With Phase 1 now operating at full capacity, we are working relentlessly to replicate this industrial success as we move forward with the construction of our second Greentech Industrial Production Plant. " ABOUT SIGMA LITHIUM Sigma Lithium (TSXV/NASDAQ: SGML, BVMF: S2GM34) is a leading global lithium producer dedicated to powering the next generation of electric vehicle batteries with carbon-neutral, socially and environmentally sustainable chemical-grade lithium concentrate. Sigma Lithium is one of the world's largest lithium producers. The Company operates at the forefront of environmental and social sustainability in the electric vehicle battery materials supply chain at its Grota do Cirilo Operation in Brazil . Here, Sigma produces Quintuple Zero Green Lithium at its state-of-the-art Greentech lithium beneficiation plant, delivering net zero carbon lithium, produced with zero carbon intensive energy, zero potable water, zero toxic chemicals and zero tailings dams. Phase 1 of the Company's operations entered commercial production in the second quarter of 2023. The Company has issued a Final Investment Decision, formally approving construction to double capacity to 520,000 tonnes of lithium concentrate through the addition of a Phase 2 expansion of its Greentech Plant. For more information about Sigma Lithium, visit https://www.sigmalithiumresources.com/ Sigma Lithium LinkedIn: Sigma Lithium Instagram: @sigmalithium Twitter: @SigmaLithium FORWARD-LOOKING STATEMENTS This news release includes certain "forward-looking information" under applicable Canadian and U.S. securities legislation, including but not limited to statements relating to timing and costs related to the general business and operational outlook of the Company, the environmental footprint of tailings and positive ecosystem impact relating thereto, donation and upcycling of tailings, timing and quantities relating to tailings and Green Lithium, achievements and projections relating to the Zero Tailings strategy, achievement of ramp-up volumes, production estimates and the operational status of the Groto do Cirilo Project, and other forward-looking information. All statements that address future plans, activities, events, estimates, expectations or developments that the Company believes, expects or anticipates will or may occur is forward-looking information, including statements regarding the potential development of mineral resources and mineral reserves which may or may not occur. Forward-looking information contained herein is based on certain assumptions regarding, among other things: general economic and political conditions; the stable and supportive legislative, regulatory and community environment in Brazil ; demand for lithium, including that such demand is supported by growth in the electric vehicle market; the Company's market position and future financial and operating performance; the Company's estimates of mineral resources and mineral reserves, including whether mineral resources will ever be developed into mineral reserves; and the Company's ability to operate its mineral projects including that the Company will not experience any materials or equipment shortages, any labour or service provider outages or delays or any technical issues. Although management believes that the assumptions and expectations reflected in the forward-looking information are reasonable, there can be no assurance that these assumptions and expectations will prove to be correct. Forward-looking information inherently involves and is subject to risks and uncertainties, including but not limited to that the market prices for lithium may not remain at current levels; and the market for electric vehicles and other large format batteries currently has limited market share and no assurances can be given for the rate at which this market will develop, if at all, which could affect the success of the Company and its ability to develop lithium operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information, future events or otherwise, except as required by law. For more information on the risks, uncertainties and assumptions that could cause our actual results to differ from current expectations, please refer to the current annual information form of the Company and other public filings available under the Company's profile at www.sedar.com . Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. FOR ADDITIONAL INFORMATION PLEASE CONTACT Matthew DeYoe , EVP Corporate Affairs & Strategic Development matthew.deyoe@sigmalithium.com.br Irina Axenova , Vice President Investor Relations irina.axenova@sigmalithium.com.br View original content to download multimedia: https://www.prnewswire.com/news-releases/sigma-lithiums-production-at-full-capacity-record-shipment-of-27-500t-of-quintuple-zero-green-lithium-to-abu-dhabis-irh-trading-company-302321451.html SOURCE Sigma Lithium Corporation

IREN announces proposed convertible notes offeringLarson Financial Group LLC Boosts Stake in FT Vest Rising Dividend Achievers Target Income ETF (BATS:RDVI)

Baylor 73, Villanova 62